30 November 2017 EMA/787886/2017 Human Medicines Evaluation Division

List of nationally authorised medicinal products

Active substance: isotretinoin (oral formulations)

Procedure no.: PSUSA/00010488/201705

30 Churchill Place ● Canary Wharf ● London E14 5EU ● United Kingdom Telephone +44 (0)20 3660 6000 Facsimile +44 (0)20 3660 5525 Send a question via our website www.ema.europa.eu/contact

An agency of the European Union

© European Medicines Agency, 2017. Reproduction is authorised provided the source is acknowledged.

Product Name (in authorisation country)

MRP/DCP Authorisation number

National Authorisation Number

MAH of product in the member state

Member State where product is authorised

REDUCAR 10mg μαλακό

not available

41918/14-6-2013

GAP S.A.

GR

not available

39324/14-6-2013

GAP S.A.

GR

NL/H/3739/002

PL 31750/0100

SUN PHARMACEUTICAL

UK

καψάκιο REDUCAR 20mg μαλακό καψάκιο Isotretinoin 20 mg soft capsules Isotretinoin 10 mg soft

INDUSTRIES EUROPE B.V. NL/H/3739/001

PL 31750/0099

capsules Izotek 10 mg, kapsułki,

DK/H/0889/001

12350

DK/H/0889/002

12349

PHARMASWISS ČESKÁ

PL

REPUBLIKA S.R.O.

miękkie Acnemin 10 mg cápsulas

UK

INDUSTRIES EUROPE B.V.

miękkie Izotek 20 mg, kapsułki,

SUN PHARMACEUTICAL

PHARMASWISS ČESKÁ

PL

REPUBLIKA S.R.O. not available

65413

LABORATORIOS VIÑAS, S.A.

ES

not available

65414

LABORATORIOS VIÑAS, S.A.

ES

not available

IS/1/16/035/01

ACTAVIS GROUP PTC EHF.

IS

not available

21122

HADJICONSTANTINOU BROS

CY

not available

21123

HADJICONSTANTINOU BROS

CY

not available

76447/10-11-11

IASIS PHARMA

GR

not available

76449/10-11-11

IASIS PHARMA

GR

not available

78135/10-11-11

IASIS PHARMA

GR

blandas Acnemin 20 mg cápsulas blandas Isotretinoin Actavis 5 mg mjúk hylki Rotaxin 10mg soft gelatin capsules Rotaxin 20mg soft gelatin capsules ISOTROIN® 10mg καψάκια μαλακά ISOTROIN® 20mg καψάκια μαλακά ISOTROIN® 40mg καψάκια μαλακά

List of nationally authorised medicinal products EMA/787886/2017

Page 2/30

Product Name (in authorisation country)

MRP/DCP Authorisation number

National Authorisation Number

MAH of product in the member state

Member State where product is authorised

ISOTROIN® 10mg

not available

20695

IASIS PHARMA

CY

not available

20693

IASIS PHARMA

CY

not available

S00714

IASIS PHARMA

CY

DK/H/0297/002

31472

ACTAVIS GROUP PTC EHF.

DK

DK/H/0297/001

31471

ACTAVIS GROUP PTC EHF.

DK

DK/H/0297/001

17179

ACTAVIS GROUP PTC EHF.

FI

DK/H/0297/002

17180

ACTAVIS GROUP PTC EHF.

FI

not available

34009 382 601 9 9

LABORATOIRES BAILLEUL SA

FR

not available

34009 382 602 5 0

LABORATOIRES BAILLEUL SA

FR

not available

358 120-4

LABORATOIRES BAILLEUL SA

FR

not available

358 121-0

LABORATOIRES BAILLEUL SA

FR

not available

358 122-7

LABORATOIRES BAILLEUL SA

FR

not available

358 116-7

LABORATOIRES BAILLEUL SA

FR

not available

358 117-3

LABORATOIRES BAILLEUL SA

FR

καψάκια μαλακά ISOTROIN® 20mg καψάκια μαλακά ISOTROIN® 40mg καψάκια μαλακά Isotretinoin “Actavis”, bløde kapsler Isotretinoin “Actavis”, bløde kapsler ISOTRETINOIN ACTAVIS 10 MG, KAPSELI, PEHMEÄ ISOTRETINOIN ACTAVIS 20 MG, KAPSELI, PEHMEÄ CONTRACNE 5 mg, capsule molle CONTRACNE 5 mg, capsule molle CONTRACNE 10 mg, capsule molle CONTRACNE 10 mg, capsule molle CONTRACNE 10 mg, capsule molle CONTRACNE 20 mg, capsule molle CONTRACNE 20 mg, capsule molle

List of nationally authorised medicinal products EMA/787886/2017

Page 3/30

Product Name (in authorisation country)

MRP/DCP Authorisation number

National Authorisation Number

MAH of product in the member state

Member State where product is authorised

CONTRACNE 20 mg,

not available

358 119-6

LABORATOIRES BAILLEUL SA

FR

not available

367 884-3

LABORATOIRES BAILLEUL SA

FR

not available

367 888-9

LABORATOIRES BAILLEUL SA

FR

DK/H/0889/001

34932

PHARMATHEN S.A.

DK

DK/H/0889/002

34933

PHARMATHEN S.A.

DK

DK/H/0889/002

21907

PHARMATHEN S.A.

FI

NL/H/902/002

RVG 27576

PHARMACHEMIE B.V

NL

not available

34009 358 110 9 7

LABORATOIRES

FR

capsule molle CONTRACNE 40 mg, capsule molle CONTRACNE 40 mg, capsule molle ISOTRETINOIN ”ORION”, BLØDE KAPSLER ISOTRETINOIN ”ORION”, BLØDE KAPSLER Isotretinoin Orion 20 mg kapseli, pehmeä Isotretinoïne 20 PCH, capsules 20 mg PROCUTA 5 mg, capsule molle PROCUTA 5 mg, capsule

EXPANSCIENCE not available

34009 357 840 3 2

molle PROCUTA 5 mg, capsule

not available

34009 358 111 5 8

not available

34009 358 112 1 9

not available

34009 357 842 6 1

LABORATOIRES

FR

LABORATOIRES

FR

EXPANSCIENCE not available

34009 358 107 8 6

molle PROCUTA 10 mg, capsule

FR

EXPANSCIENCE

molle PROCUTA 10 mg, capsule

LABORATOIRES EXPANSCIENCE

molle PROCUTA 5 mg, capsule

FR

EXPANSCIENCE

molle PROCUTA 5 mg, capsule

LABORATOIRES

LABORATOIRES

FR

EXPANSCIENCE not available

molle

List of nationally authorised medicinal products EMA/787886/2017

34009 357 838 9 9

LABORATOIRES

FR

EXPANSCIENCE

Page 4/30

Product Name (in authorisation country)

MRP/DCP Authorisation number

National Authorisation Number

MAH of product in the member state

Member State where product is authorised

PROCUTA 10 mg, capsule

not available

34009 358 108 4 7

LABORATOIRES

FR

molle PROCUTA 10 mg, capsule

EXPANSCIENCE not available

34009 358 109 0 8

molle PROCUTA 10 mg, capsule

not available

34009 357 839 5 0

not available

34009 358 104 9 6

not available

34009 357 836 6 0

not available

34009 358 105 5 7

not available

34009 358 106 1 8

not available

34009 357 837 2 1

FR

LABORATOIRES

FR

LABORATOIRES

FR

LABORATOIRES

FR

EXPANSCIENCE not available

34009 367 880 8 4

molle Isotretinoina difa 40 mg

LABORATOIRES

EXPANSCIENCE

molle PROCUTA 40 mg, capsule

FR

EXPANSCIENCE

molle PROCUTA 20 mg, capsule

LABORATOIRES

EXPANSCIENCE

molle PROCUTA 20 mg, capsule

FR

EXPANSCIENCE

molle PROCUTA 20 mg, capsule

LABORATOIRES EXPANSCIENCE

molle PROCUTA 20 mg, capsule

FR

EXPANSCIENCE

molle PROCUTA 20 mg, capsule

LABORATOIRES

LABORATOIRES

FR

EXPANSCIENCE DK/H/1749/001

039964010

DIFA COOPER S.P.A.

IT

DK/H/1749/001

039964022

DIFA COOPER S.P.A.

IT

DK/H/1749/001

039964034

DIFA COOPER S.P.A.

IT

DK/H/1749/001

039964046

DIFA COOPER S.P.A.

IT

DK/H/1749/001

039964059

DIFA COOPER S.P.A.

IT

capsule molli Isotretinoina difa 40 mg capsule molli Isotretinoina difa 40 mg capsule molli Isotretinoina difa 40 mg capsule molli Isotretinoina difa 40 mg capsule molli

List of nationally authorised medicinal products EMA/787886/2017

Page 5/30

Product Name (in authorisation country)

MRP/DCP Authorisation number

National Authorisation Number

MAH of product in the member state

Member State where product is authorised

Isotretinoina difa 40 mg

DK/H/1749/001

039964061

DIFA COOPER S.P.A.

IT

DK/H/1749/001

039964073

DIFA COOPER S.P.A.

IT

DK/H/1749/001

039964085

DIFA COOPER S.P.A.

IT

DK/H/1749/001

039964097

DIFA COOPER S.P.A.

IT

DK/H/1749/001

039964109

DIFA COOPER S.P.A.

IT

not available

IS/1/16/035/02

ACTAVIS GROUP PTC EHF.

IS

Ciscutan 10 mg – Kapseln

AT/H/0293/001

1-24652

PELPHARMA HANDELS GMBH

AT

Ciscutan 20 mg – Kapseln

AT/H/0293/002

1-24653

PELPHARMA HANDELS GMBH

AT

Isdiben 10 mg capsule

UK/H/3577/002

041853045

ISDIN S.R.L.

IT

UK/H/3577/002

041853058

ISDIN S.R.L.

IT

UK/H/3577/002

041853060

ISDIN S.R.L.

IT

UK/H/3577/002

PL 04569/1344

GENERICS [UK] LIMITED

UK

UK/H/3577/003

PL 04569/1345

GENERICS [UK] LIMITED

UK

UK/H/3577/004

PL 04569/1346

GENERICS [UK] LIMITED

UK

capsule molli Isotretinoina difa 40 mg capsule molli Isotretinoina difa 40 mg capsule molli Isotretinoina difa 40 mg capsule molli Isotretinoina difa 40 mg capsule molli Isotretinoin Actavis 40 mg mjúk hylki

molli Isdiben 10 mg capsule molli Isdiben 10 mg capsule molli Isotretinoin 10 mg Soft Capsules Isotretinoin 20 mg Soft Capsules Isotretinoin 40 mg Soft Capsules

List of nationally authorised medicinal products EMA/787886/2017

Page 6/30

Product Name (in authorisation country)

MRP/DCP Authorisation number

National Authorisation Number

MAH of product in the member state

Member State where product is authorised

Isotretinoin 5 mg Soft

UK/H/3577/001

PL 04569/1343

GENERICS [UK] LIMITED

UK

UK/H/3577/004

76.045

ISDIN, S.A.

ES

UK/H/3577/001

041853019

ISDIN S.R.L.

IT

UK/H/3577/001

041853021

ISDIN S.R.L.

IT

UK/H/3577/001

041853033

ISDIN S.R.L.

IT

UK/H/3577/003

041853072

ISDIN S.R.L.

IT

UK/H/3577/003

041853084

ISDIN S.R.L.

IT

UK/H/3577/003

041853096

ISDIN S.R.L.

IT

UK/H/3577/004

041853108

ISDIN S.R.L.

IT

UK/H/3577/004

041853110

ISDIN S.R.L.

IT

UK/H/3577/004

041853122

ISDIN S.R.L.

IT

not available

NL 36265

ARROW GENERIQUES

FR

not available

NL 26226

ARROW GENERIQUES

FR

not available

NL 26227

ARROW GENERIQUES

FR

Capsules Isdiben 40 mg cápsulas blandas Isdiben 5 mg capsule molli Isdiben 5 mg capsule molli Isdiben 5 mg capsule molli Isdiben 20 mg capsule molli Isdiben 20 mg capsule molli Isdiben 20 mg capsule molli Isdiben 40 mg capsule molli Isdiben 40 mg capsule molli Isdiben 40 mg capsule molli ACNETRAIT 5 mg, capsule molle ACNETRAIT 10 mg, capsule molle ACNETRAIT 20 mg, capsule molle

List of nationally authorised medicinal products EMA/787886/2017

Page 7/30

Product Name (in authorisation country)

MRP/DCP Authorisation number

National Authorisation Number

MAH of product in the member state

Member State where product is authorised

ACNETRAIT 40 mg,

not available

NL 36266

ARROW GENERIQUES

FR

BE/H/0193/002

0019/05060040

EUROGENERICS SA

LU

BE/H/0193/002

BE270173

EUROGENERICS N.V./S.A.

BE

BE/H/0193/002

BE270173

EUROGENERICS N.V./S.A.

BE

BE/H/0193/002

BE270173

EUROGENERICS N.V./S.A.

BE

not available

PL 14894/0161

RANBAXY UK LTD

UK

not available

PL 14894/0162

RANBAXY UK LTD

UK

not available

12054

VITAMA S.A.

PL

not available

12054

VITAMA S.A.

PL

not available

12053

VITAMA S.A.

PL

not available

12053

VITAMA S.A.

PL

not available

12053

VITAMA S.A.

PL

BE/H/0193/001

0019/05060039

EUROGENERICS SA

LU

BE/H/0193/001

BE266296

EUROGENERICS N.V./S.A.

BE

capsule molle Isotretinoïne EG 20 mg capsules molles Isotretinoïne EG 20 mg zachte capsules Isotretinoïne EG 20 mg Weichkapseln Isotretinoïne EG 20 mg capsules molles Isotretinoin 10mg Capsules Isotretinoin 20mg Capsules Tretoskin, 10 mg, kapsułki miękkie Tretoskin, 10 mg, kapsułki miękkie Tretoskin, 20 mg, kapsułki miękkie Tretoskin, 20 mg, kapsułki miękkie Tretoskin, 20 mg, kapsułki miękkie Isotretinoïne EG 10 mg capsules molles Isotretinoïne EG 10 mg zachte capsules

List of nationally authorised medicinal products EMA/787886/2017

Page 8/30

Product Name (in authorisation country)

MRP/DCP Authorisation number

National Authorisation Number

MAH of product in the member state

Member State where product is authorised

Isotretinoïne EG 10 mg

BE/H/0193/001

BE266296

EUROGENERICS N.V./S.A.

BE

BE/H/0193/001

BE266296

EUROGENERICS N.V./S.A.

BE

not available

7661/2015/0 I

ROCHE ROMANIA SRL

RO

not available

20030084

ROCHE BULGARIA EOOD

BG

not available

HR-H-462694255

ROCHE D.O.O.

HR

AT/H/0164/001

PL 40739/0002

ENNOGEN HEALTHCARE

UK

Weichkapseln Isotrétinoïne EG 10 mg capsules molles Roaccutane I 0 mg capsule moi Роакутан 20 mg капсули, меки Roaccutane 10 mg meke kapsule Isotretinoin 5 mg capsules Isotretinoin 20mg soft

LIMITED not available

PL 40739/0001

capsules Reticutan 20mg soft

UK

LIMITED not available

PL 40739/0001

capsules Ciscumed 5 mg – Kapseln

ENNOGEN HEALTHCARE ENNOGEN HEALTHCARE

UK

LIMITED AT/H/0164/001

1-27153

ENNOGEN HEALTHCARE

AT

LIMITED Isotretinoína Orotrex 10

not available

5174693

mg cápsulas moles

LABORATÓRIO MEDINFAR -

PT

PRODUTOS FARMACÊUTICOS, S.A.

Isotretinoína Orotrex 10

not available

4882494

mg cápsulas moles

LABORATÓRIO MEDINFAR -

PT

PRODUTOS FARMACÊUTICOS, S.A.

Isotretinoína Orotrex 10

not available

mg cápsulas moles

5174792

LABORATÓRIO MEDINFAR -

PT

PRODUTOS FARMACÊUTICOS, S.A.

List of nationally authorised medicinal products EMA/787886/2017

Page 9/30

Product Name (in authorisation country)

MRP/DCP Authorisation number

National Authorisation Number

MAH of product in the member state

Member State where product is authorised

Isotretinoína Orotrex 20

not available

4882593

LABORATÓRIO MEDINFAR -

PT

mg cápsulas moles

PRODUTOS FARMACÊUTICOS, S.A.

Isotretinoína Orotrex 20

not available

5174891

mg cápsulas moles

LABORATÓRIO MEDINFAR -

PT

PRODUTOS FARMACÊUTICOS, S.A.

ROCNE

not available

87229/7-12-2009

PHARMATHEN S.A.

GR

ROCNE

not available

87230/7-12-2009

PHARMATHEN S.A.

GR

Aknenormin 10 mg

DE/H/1702/001

55003.00.00

ALMIRALL HERMAL GMBH

DE

DE/H/1702/001/MR

46/138/05-C

ALMIRALL HERMAL GMBH

CZ

DE/H/1702/001

OGYI-T-10170/01

ALMIRALL HERMAL GMBH

HU

DE/H/1702/001

11427

ALMIRALL HERMAL GMBH

PL

DE/H/1702/001

46/0130/05-S

ALMIRALL HERMAL GMBH

SK

DE/H/1702/002

55003.01.00

ALMIRALL HERMAL GMBH

DE

DE/H/1702/002/MR

46/139/05-C

ALMIRALL HERMAL GMBH

CZ

DE/H/1702/002

OGYI-T-10171/01

ALMIRALL HERMAL GMBH

HU

DE/H/1702/002/MR

46/0129/05-S

ALMIRALL HERMAL GMBH

SK

Weichkapseln Aknenormin 10 mg měkké tobolky Aknenormin 10 mg lágy kapszula Aknenormin, 10 mg, kapsulki miękkie Aknenormin 10 Mäkké kapsuly Aknenormin 20 mg Weichkapseln Aknenormin 20 mg měkké tobolky Aknenormin 20 mg lágy kapszula Aknenormin 20 Mäkké kapsuly

List of nationally authorised medicinal products EMA/787886/2017

Page 10/30

Product Name (in authorisation country)

MRP/DCP Authorisation number

National Authorisation Number

MAH of product in the member state

Member State where product is authorised

Aknenormin, 20 mg,

DE/H/1702/002

11426

ALMIRALL HERMAL GMBH

PL

DK/H/2242/001

21632

ACTAVIS GROUP PTC EHF.

PL

DK/H/2242/002

21633

ACTAVIS GROUP PTC EHF.

PL

DK/H/2242/001

OGYI-T-22560/02

ACTAVIS GROUP PTC EHF.

HU

DK/H/2242/001

OGYI-T-22560/03

ACTAVIS GROUP PTC EHF.

HU

DK/H/2242/001

OGYI-T-22560/04

ACTAVIS GROUP PTC EHF.

HU

DK/H/2242/001

OGYI-T-22560/05

ACTAVIS GROUP PTC EHF.

HU

DK/H/2242/001

OGYI-T-22560/11

ACTAVIS GROUP PTC EHF.

HU

DK/H/2242/002

OGYI-T-22560/07

ACTAVIS GROUP PTC EHF.

HU

DK/H/2242/002

OGYI-T-22560/08

ACTAVIS GROUP PTC EHF.

HU

DK/H/2242/002

OGYI-T-22560/09

ACTAVIS GROUP PTC EHF.

HU

DK/H/2242/002

OGYI-T-22560/10

ACTAVIS GROUP PTC EHF.

HU

DK/H/2242/002

OGYI-T-22560/12

ACTAVIS GROUP PTC EHF.

HU

DK/H/2242/001

51479

ACTAVIS GROUP PTC EHF.

DK

kapsułki miękkie ACTAVEN, 10 MG, KAPSULKI, MIEKKIE ACTAVEN, 20 MG, KAPSUŁKI, MIĘKKIE Inerta 10 mg lágy kapszula Inerta 10 mg lágy kapszula Inerta 10 mg lágy kapszula Inerta 10 mg lágy kapszula Inerta 10 mg lágy kapszula Inerta 20 mg lágy kapszula Inerta 20 mg lágy kapszula Inerta 20 mg lágy kapszula Inerta 20 mg lágy kapszula Inerta 20 mg lágy kapszula ACNENOR, BLØDE KAPSLER

List of nationally authorised medicinal products EMA/787886/2017

Page 11/30

Product Name (in authorisation country)

MRP/DCP Authorisation number

National Authorisation Number

MAH of product in the member state

Member State where product is authorised

Inerta 10 mg lágy

DK/H/2242/001

OGYI-T-22560/01

ACTAVIS GROUP PTC EHF.

HU

DK/H/2242/001

48555

ACTAVIS GROUP PTC EHF.

SE

DK/H/2242/001

46/0418/13-S

ACTAVIS GROUP PTC EHF.

SK

DK/H/2242/002

51480

ACTAVIS GROUP PTC EHF.

DK

DK/H/2242/002

OGYI-T-22560/06-10

ACTAVIS GROUP PTC EHF.

HU

DK/H/2242/002

48556

ACTAVIS GROUP PTC EHF.

SE

DK/H/2242/002

46/0419/13-S

ACTAVIS GROUP PTC EHF.

SK

Pharmiso

DK/H/0300/002

31478

HEXAL AG

DK

Isotret-Hexal 20 mg

DK/H/0300/002

54100.01.00

HEXAL AG

DE

DK/H/0300/001

54100.00.00

HEXAL AG

DE

NL/H/0593/002

RVG 26548

SANDOZ B.V.

NL

NL/H/0593/001

RVG 26547

SANDOZ B.V.

NL

Accutin

not available

31531

SANDOZ A/S

DK

Accutin

not available

31532

SANDOZ A/S

DK

Pharmiso

DK/H/0300/001

31477

HEXAL AG

DK

kapszula ISOTRETINOIN ACTAVIS 10 MG KAPSLAR, MJUKA ISOTRETINOIN ACTAVIS 10 MG MÄKKÉ KAPSULY ACNENOR, BLØDE KAPSLER Inerta 20 mg lágy kapszula ISOTRETINOIN ACTAVIS 20 MG KAPSLAR, MJUKA ISOTRETINOIN ACTAVIS 20 MG MÄKKÉ KAPSULY

Kapseln Isotret-HEXAL 10 mg Kapseln ISOTRETINOÏNE SANDOZ 20 MG, CAPSULES ISOTRETINOÏNE SANDOZ 10 MG, CAPSULES

List of nationally authorised medicinal products EMA/787886/2017

Page 12/30

Product Name (in authorisation country)

MRP/DCP Authorisation number

National Authorisation Number

MAH of product in the member state

Member State where product is authorised

Isotretinoïne Sandoz 20

NL/H/0593/002

BE291137

SANDOZ N.V.

BE

NL/H/0593/001

PL 04416/1032

SANDOZ LTD

UK

NL/H/0593/002

PL 04416/1033

SANDOZ LTD

UK

not available

66320/14/07-01-2015

TARGET PHARMA SINGLE

GR

mg zachte capsules Isotretinoin 10 mg Capsules Isotretinoin 20 mg Capsules Tretin 10mg , καψάκια μαλακά Tretin 20mg, καψάκια

MEMBER PRIVATE LTD not available

85176/14/07-01-2015

PT/H/1878/001

54253.00.00

μαλακά Isotretinoin PUREN 10 mg

PUREN PHARMA GMBH & CO.

DE

KG PT/H/1878/002

54253.01.00

Weichkapseln Isotretinoïne Aurobindo

GR

MEMBER PRIVATE LTD

Weichkapseln Isotretinoin PUREN 20 mg

TARGET PHARMA SINGLE

PUREN PHARMA GMBH & CO.

DE

KG PT/H/1878/001-002

RVG 27577

AUROBINDO PHARMA B.V.

NL

PT/H/1878/001-002

RVG 27578

AUROBINDO PHARMA B.V.

NL

PT/H/1878/001

4057584

AUROVITAS UNIPESSOAL,

PT

PT/H/1878/001

4057683

PT/H/1878/001

4057782

10 mg, capsules Isotretinoïne Aurobindo 20 mg, capsules Isotretinoína Aurovitas 10 mg Cápsulas moles Isotretinoína Aurovitas 10

LDA.

mg Cápsulas moles Isotretinoína Aurovitas 10

AUROVITAS UNIPESSOAL,

PT

LDA. PT/H/1878/001

4057881

mg Cápsulas moles Isotretinoína Aurovitas 10

PT

LDA.

mg Cápsulas moles Isotretinoína Aurovitas 10

AUROVITAS UNIPESSOAL,

AUROVITAS UNIPESSOAL,

PT

LDA. PT/H/1878/001

mg Cápsulas moles

List of nationally authorised medicinal products EMA/787886/2017

4057980

AUROVITAS UNIPESSOAL,

PT

LDA.

Page 13/30

Product Name (in authorisation country)

MRP/DCP Authorisation number

National Authorisation Number

MAH of product in the member state

Member State where product is authorised

Isotretinoína Aurovitas 20

PT/H/1878/002

4058087

AUROVITAS UNIPESSOAL,

PT

mg Cápsulas moles Isotretinoína Aurovitas 20

LDA. PT/H/1878/002

4058186

mg Cápsulas moles Isotretinoína Aurovitas 20

PT/H/1878/002

4058285

PT/H/1878/002

4058384

PT/H/1878/002

4058483

PT/H/1878/002

PT/H/1878/002

PT

AUROVITAS UNIPESSOAL,

PT

AUROVITAS UNIPESSOAL,

PT

LDA. PT/H/1878/001

PT/H/1878/001

mg Cápsulas moles Accuran, 10 mg/cap,

AUROVITAS UNIPESSOAL,

LDA.

mg Cápsulas moles Isotretinoína Aurovitas 10

PT

LDA.

mg Cápsulas moles Isotretinoína Aurovitas 20

AUROVITAS UNIPESSOAL, LDA.

mg Cápsulas moles Isotretinoína Aurovitas 20

PT

LDA.

mg Cápsulas moles Isotretinoína Aurovitas 20

AUROVITAS UNIPESSOAL,

AUROVITAS UNIPESSOAL,

PT

LDA. not available

18066/21-03-2012

NEXUS MEDICALS S.A.

GR

not available

18066/21-03-2012

NEXUS MEDICALS S.A.

GR

ACNOGEN/GENEPHARM

not available

38591/10/18-04-2011

GENEPHARM S.A.

GR

ACNOGEN/GENEPHARM

not available

38594/10/18-04-2011

GENEPHARM S.A.

GR

CURACNÉ 10 mg, capsule

FR/H/0250/002

34009 358 129 1 9

SAS PIERRE FABRE

FR

καψάκιο, μαλακό Accuran, 20 mg/cap, καψάκιο, μαλακό

molle ISOCURAL 10 mg, zachte

DERMATOLOGIE FR/H/0250/002

BE280411

PIERRE FABRE BENELUX S.A.

BE

FR/H/0250/002

67.570

PIERRE FABRE IBERICA /

ES

capsules ISOACNÉ 10 mg cápsulas blandas

List of nationally authorised medicinal products EMA/787886/2017

SPAIN

Page 14/30

Product Name (in authorisation country)

MRP/DCP Authorisation number

National Authorisation Number

MAH of product in the member state

Member State where product is authorised

ISORIAC 10 mg, capsule

FR/H/0250/002

037551025

PIERRE FABRE ITALIA S.P.A.

IT

FR/H/0250/002

1128/09020250

PIERRE FABRE

LU

molli CURACNÉ Gé 10 mg, capsule molle Curacne 10 mg Kapsulki

DERMATOLOGIE FR/H/0250/002

11919

miekkie Isotretinoína Pierre Fabre

PIERRE FABRE

PL

DERMATOLOGIE FR/H/0250/002

5732482

10 mg cápsulas moles

PIERRE FABRE DERMO-

PT

COSMETIQUE PORTUGAL, LDA

CURACNÉ 20 mg, capsule

FR/H/0250/003

34009 358 115 0 9

molle ISOCURAL 20 mg,

SAS PIERRE FABRE

FR

DERMATOLOGIE FR/H/0250/003

BE280427

PIERRE FABRE BENELUX S.A.

BE

FR/H/0250/003

67.571

PIERRE FABRE IBERICA /

ES

FR/H/0250/003

037551076

PIERRE FABRE ITALIA S.P.A.

IT

FR/H/0250/003

1128/09020249

PIERRE FABRE

LU

capsules molles ISOACNÉ 20 mg cápsulas blandas ISORIAC 20 mg, capsule

SPAIN

molli CURACNÉ Gé 20 mg, capsule molle Curacne 20 mg Kapsulki

DERMATOLOGIE FR/H/0250/003

11918

miekkie Isotretinoína Pierre Fabre

PIERRE FABRE

PL

DERMATOLOGIE FR/H/0250/003

5732987

20 mg cápsulas moles

PIERRE FABRE DERMO-

PT

COSMETIQUE PORTUGAL, LDA

CURACNÉ 40 mg, capsule

FR/H/0250/004

367 603-4

molle ISOCURAL 40 mg,

SAS PIERRE FABRE

FR

DERMATOLOGIE FR/H/0250/004

BE 334047

PIERRE FABRE BENELUX S.A.

BE

capsules molles

List of nationally authorised medicinal products EMA/787886/2017

Page 15/30

Product Name (in authorisation country)

MRP/DCP Authorisation number

National Authorisation Number

MAH of product in the member state

Member State where product is authorised

ISOACNÉ 40 mg cápsulas

FR/H/0250/004

69.927

PIERRE FABRE IBERICA /

ES

blandas CURACNÉ 40 mg, capsule

SPAIN FR/H/0250/004

1128/08010002

molle Curacne 40 mg Kapsułki

FR/H/0250/004

14709

PIERRE FABRE

PL

DERMATOLOGIE FR/H/0250/001

34009 358 123 3 9

molle ISOCURAL 5 mg,

LU

DERMATOLOGIE

miękkie CURACNÉ 5 mg, capsule

PIERRE FABRE

SAS PIERRE FABRE

FR

DERMATOLOGIE FR/H/0250/001

BE280402

PIERRE FABRE BENELUX S.A.

BE

FR/H/0250/001

67.464

PIERRE FABRE IBERICA /

ES

capsules molles ISOACNÉ 5 mg cápsulas blandas CURACNÉ Gé 5 mg,

SPAIN FR/H/0250/001

1128/09020251

capsule molle CURACNÉ 40 mg|mäkké

LU

DERMATOLOGIE FR/H/0250/001

11920

kapsuly Isotretinoína Pierre Fabre

PIERRE FABRE PIERRE FABRE

PL

DERMATOLOGIE FR/H/0250/001

5731989

5 mg, cápsulas moles

PIERRE FABRE DERMO-

PT

COSMETIQUE PORTUGAL, LDA

ISOCURAL 10 mg,

FR/H/0250/002

BE280411

PIERRE FABRE BENELUX S.A.

BE

FR/H/0250/003

BE280427

PIERRE FABRE BENELUX S.A.

BE

FR/H/0250/004

BE334047

PIERRE FABRE BENELUX S.A.

BE

FR/H/0250/001

BE280402

PIERRE FABRE BENELUX S.A.

BE

capsules molles ISOCURAL 20 mg, zachte capsules ISOCURAL 40 mg, zachte capsules ISOCURAL 5 mg, zachte capsules

List of nationally authorised medicinal products EMA/787886/2017

Page 16/30

Product Name (in authorisation country)

MRP/DCP Authorisation number

National Authorisation Number

MAH of product in the member state

Member State where product is authorised

CURACNÉ 10 mg, capsule

FR/H/0250/002

34009 358 131 6 9

SAS PIERRE FABRE

FR

molle CURACNÉ 10 mg, capsule

DERMATOLOGIE FR/H/0250/002

34009 358 134 5 9

molle CURACNÉ 10 mg, capsule

FR/H/0250/002

34009 358 132 2 0

FR/H/0250/002

34009 358 133 9 8

FR/H/0250/003

34009 358 135 1 0

FR/H/0250/003

34009 358 136 8 8

FR/H/0250/003

34009 358 157 5 0

FR/H/0250/003

34009 358 158 1 1

FR/H/0250/001

34009 358 125 6 8

FR/H/0250/001

34009 358 126 2 9

FR/H/0250/001

34009 358 127 9 7

FR/H/0250/001

34009 358 128 5 8

SAS PIERRE FABRE

FR

SAS PIERRE FABRE

FR

SAS PIERRE FABRE

FR

SAS PIERRE FABRE

FR

SAS PIERRE FABRE

FR

DERMATOLOGIE

molle Isotretinoína Pierre Fabre

FR

DERMATOLOGIE

molle CURACNÉ 5 mg, capsule

SAS PIERRE FABRE

DERMATOLOGIE

molle CURACNÉ 5 mg, capsule

FR

DERMATOLOGIE

molle CURACNÉ 5 mg, capsule

SAS PIERRE FABRE

DERMATOLOGIE

molle CURACNÉ 5 mg, capsule

FR

DERMATOLOGIE

molle CURACNÉ 20 mg, capsule

SAS PIERRE FABRE

DERMATOLOGIE

molle CURACNÉ 20 mg, capsule

FR

DERMATOLOGIE

molle CURACNÉ 20 mg, capsule

SAS PIERRE FABRE DERMATOLOGIE

molle CURACNÉ 20 mg, capsule

FR

DERMATOLOGIE

molle CURACNÉ 10 mg, capsule

SAS PIERRE FABRE

SAS PIERRE FABRE

FR

DERMATOLOGIE FR/H/0250/002

10 mg cápsulas moles

5732581

PIERRE FABRE DERMO-

PT

COSMETIQUE PORTUGAL, LDA

List of nationally authorised medicinal products EMA/787886/2017

Page 17/30

Product Name (in authorisation country)

MRP/DCP Authorisation number

National Authorisation Number

MAH of product in the member state

Member State where product is authorised

Isotretinoína Pierre Fabre

FR/H/0250/002

5732680

PIERRE FABRE DERMO-

PT

10 mg cápsulas moles

COSMETIQUE PORTUGAL, LDA

Isotretinoína Pierre Fabre

FR/H/0250/002

5732789

10 mg cápsulas moles

PIERRE FABRE DERMO-

PT

COSMETIQUE PORTUGAL, LDA

Isotretinoína Pierre Fabre

FR/H/0250/002

5732888

10 mg cápsulas moles

PIERRE FABRE DERMO-

PT

COSMETIQUE PORTUGAL, LDA

Isotretinoína Pierre Fabre

FR/H/0250/003

5733084

20 mg cápsulas moles

PIERRE FABRE DERMO-

PT

COSMETIQUE PORTUGAL, LDA

Isotretinoína Pierre Fabre

FR/H/0250/003

5733183

20 mg cápsulas moles

PIERRE FABRE DERMO-

PT

COSMETIQUE PORTUGAL, LDA

Isotretinoína Pierre Fabre

FR/H/0250/003

5733282

20 mg cápsulas moles

PIERRE FABRE DERMO-

PT

COSMETIQUE PORTUGAL, LDA

Isotretinoína Pierre Fabre

FR/H/0250/003

5733381

20 mg cápsulas moles

PIERRE FABRE DERMO-

PT

COSMETIQUE PORTUGAL, LDA

Isotretinoína Pierre Fabre

FR/H/0250/001

5732086

5 mg, cápsulas moles

PIERRE FABRE DERMO-

PT

COSMETIQUE PORTUGAL, LDA

Isotretinoína Pierre Fabre

FR/H/0250/001

5 mg, cápsulas moles

5732185

PIERRE FABRE DERMO-

PT

COSMETIQUE PORTUGAL, LDA

List of nationally authorised medicinal products EMA/787886/2017

Page 18/30

Product Name (in authorisation country)

MRP/DCP Authorisation number

National Authorisation Number

MAH of product in the member state

Member State where product is authorised

Isotretinoína Pierre Fabre

FR/H/0250/001

5732284

PIERRE FABRE DERMO-

PT

5 mg, cápsulas moles

COSMETIQUE PORTUGAL, LDA

Isotretinoína Pierre Fabre

FR/H/0250/001

5732383

5 mg, cápsulas moles

PIERRE FABRE DERMO-

PT

COSMETIQUE PORTUGAL, LDA

CURACNÉ 10 mg měkká

FR/H/0250/002

46/056/06-C

tobolka CURACNÉ 20 mg měkká

FR/H/0250/003

46/054/06-C

PIERRE FABRE

CZ

DERMATOLOGIE FR/H/0250/004

46/095/08-C

FR/H/0250/004

46/0119/08-S

tobolka CURACNÉ 40 mg mäkké

CZ

DERMATOLOGIE

tobolka CURACNÉ 40 mg, měkká

PIERRE FABRE

PIERRE FABRE

CZ

DERMATOLOGIE

kapsuly

SAS PIERRE FABRE

SK

DERMATOLOGIE

Ciscutan 30 mg – Kapseln

not available

135651

PELPHARMA HANDELS GMBH

AT

AISOSKIN 10 mg capsule

not available

035258019

FIDIA FARMACEUTICI S.P.A

IT

not available

035258021

FIDIA FARMACEUTICI S.P.A

IT

UK/H/0504/002

66.121

ISDIN, S.A.

ES

UK/H/0504/003

66.122

ISDIN, S.A.

ES

UK/H/0504/002

RVG 27573

MYLAN B.V.

NL

UK/H/0504/003

RVG 27574

MYLAN B.V.

NL

molli AISOSKIN 20 mg capsule molli Isdiben 10 mg cápsulas blandas Isdiben 20 mg cápsulas blandas Isotretinoïne Mylan 10 mg, zachte capsules Isotretinoïne Mylan 20 mg, zachte capsules

List of nationally authorised medicinal products EMA/787886/2017

Page 19/30

Product Name (in authorisation country)

MRP/DCP Authorisation number

National Authorisation Number

MAH of product in the member state

Member State where product is authorised

Isotretinoin 10 mg Soft

UK/H/0504/002

PL 04569/0725

GENERICS [UK] LIMITED

UK

UK/H/0504/003

PL 04569/0724

GENERICS [UK] LIMITED

UK

UK/H/0504/001

PL 04569/0726

GENERICS [UK] LIMITED

UK

not available

OGYI-T-20238/05

TEVA MAGYARORSZÁG ZRT

HU

not available

OGYI-T-20238/04

TEVA MAGYARORSZÁG ZRT

HU

not available

OGYI-T-20238/10

TEVA MAGYARORSZÁG ZRT

HU

not available

OGYI-T-20238/06

TEVA MAGYARORSZÁG ZRT

HU

not available

OGYI-T-20238/02

TEVA MAGYARORSZÁG ZRT

HU

not available

OGYI-T-20238/07

TEVA MAGYARORSZÁG ZRT

HU

not available

OGYI-T-20238/01

TEVA MAGYARORSZÁG ZRT

HU

not available

OGYI-T-20238/03

TEVA MAGYARORSZÁG ZRT

HU

not available

OGYI-T-20238/09

TEVA MAGYARORSZÁG ZRT

HU

not available

OGYI-T-20238/08

TEVA MAGYARORSZÁG ZRT

HU

not available

1-27652

PELPHARMA HANDELS GMBH

AT

Capsules Isotretinoin 20 mg Soft Capsules Isotretinoin 5 mg Soft Capsules Isotretinoin-Teva 10 mg lágy kapszula Isotretinoin-Teva 10 mg lágy kapszula Isotretinoin-Teva 20 mg lágy kapszula Isotretinoin-Teva 20 mg lágy kapszula Isotretinoin-Teva 10 mg lágy kapszula Isotretinoin-Teva 20 mg lágy kapszula Isotretinoin-Teva 10 mg lágy kapszula Isotretinoin-Teva 10 mg lágy kapszula Isotretinoin-Teva 20 mg lágy kapszula Isotretinoin-Teva 20 mg lágy kapszula Ciscutan 40 mg – Kapseln

List of nationally authorised medicinal products EMA/787886/2017

Page 20/30

Product Name (in authorisation country)

MRP/DCP Authorisation number

National Authorisation Number

MAH of product in the member state

Member State where product is authorised

MAYESTA 10 mg cápsulas

not available

69.571

ALFASIGMA ESPAÑA, S.L.

ES

not available

69.572

ALFASIGMA ESPAÑA, S.L.

ES

Isoderm 10 mg

not available

48903.00.00

DERMAPHARM AG

DE

Isoderm 20 mg

not available

48903.01.00

DERMAPHARM AG

DE

Isoderm, 10 mg,

not available

18136

SUN-FARM SP. Z.O.O.

PL

not available

18137

SUN-FARM SP. Z.O.O.

PL

Ciscutan 5 mg – Kapseln

not available

1-29997

PELPHARMA HANDELS GMBH

AT

Isotretinoin ratiopharm

DK/H/0298/002

IS/1/14/036/01

RATIOPHARM GMBH

IS

DK/H/0298/001

17152

RATIOPHARM GMBH

FI

DK/H/0298/001

036083018

DIFA COOPER S.P.A.

IT

DK/H/0298/001

036083020

DIFA COOPER S.P.A.

IT

DK/H/0298/001

036083032

DIFA COOPER S.P.A.

IT

DK/H/0298/001

036083044

DIFA COOPER S.P.A.

IT

DK/H/0298/001-002

036083057/M

DIFA COOPER S.P.A.

IT

blandas MAYESTA 20 mg cápsulas blandas

kapsułki, miękkie Isoderm, 20 mg, kapsulki, miekkie

20 mg mjúk hylki Isotretinoin ratiopharm 20 mg kapsel, mjuk Isotretinoina Difa Cooper 10 mg capsule molli Isotretinoina Difa Cooper 10 mg capsule molli Isotretinoina Difa Cooper 10 mg capsule molli Isotretinoina Difa Cooper 10 mg capsule molli Isotretinoina Difa Cooper 10 mg capsule molli

List of nationally authorised medicinal products EMA/787886/2017

Page 21/30

Product Name (in authorisation country)

MRP/DCP Authorisation number

National Authorisation Number

MAH of product in the member state

Member State where product is authorised

Isotretinoina Difa Cooper

DK/H/0298/002

036083069/M

DIFA COOPER S.P.A.

IT

DK/H/0298/002

036083071/M

DIFA COOPER S.P.A.

IT

DK/H/0298/002

036083083/M

DIFA COOPER S.P.A.

IT

DK/H/0298/002

036083095/M

DIFA COOPER S.P.A.

IT

DK/H/0298/002

036083107/M

DIFA COOPER S.P.A.

IT

DK/H/0298/002

1-24649

RATIOPHARM ARZNEIMITTEL

AT

20 mg capsule molli Isotretinoina Difa Cooper 20 mg capsule molli Isotretinoina Difa Cooper 20 mg capsule molli Isotretinoina Difa Cooper 20 mg capsule molli Isotretinoina Difa Cooper 20 mg capsule molli Isotretinoin „ratiopharm“ 20 mg –

VERTRIEBS-GMBH

Kapseln Isotretinoin-ratiopharm®

DK/H/0298/002

54096.01.00

RATIOPHARM GMBH

DE

DK/H/0298/001

54096.00.00

RATIOPHARM GMBH

DE

DK/H/0298/001

1-24648

RATIOPHARM ARZNEIMITTEL

AT

20 mg Weichkapseln Isotretinoin-ratiopharm® 10 mg Weichkapseln Isotretinoin „ratiopharm“ 10 mg –

VERTRIEBS-GMBH

Kapseln Isotretinoin ratiopharm

DK/H/0298/001

17152

RATIOPHARM GMBH

FI

DK/H/0298/001

31473

RATIOPHARM GMBH

DK

DK/H/0298/002

31474

RATIOPHARM GMBH

DK

DK/H/0368/001

IS/1/02/035/01

ACTAVIS HF.

IS

20 mg kapseli, pehmeä Isotretinoin ”ratiopharm”, bløde kapsler Isotretinoin ”ratiopharm”, bløde kapsler Decutan 10 mg hylki, mjúk

List of nationally authorised medicinal products EMA/787886/2017

Page 22/30

Product Name (in authorisation country)

MRP/DCP Authorisation number

National Authorisation Number

MAH of product in the member state

Member State where product is authorised

Decutan 20 mg hylki,

DK/H/0368/002

IS/1/02/035/02

ACTAVIS HF.

IS

DK/H/0368/002

33137

ACTAVIS GROUP PTC EHF.

DK

DK/H/0368/001

33136

ACTAVIS GROUP PTC EHF.

DK

not available

MA155/00501

ACTAVIS GROUP HF.

MT

not available

MA155/00502

ACTAVIS GROUP HF.

MT

DK/H/1060/001

47763

ORIFARM GENERICS A/S

SE

DK/H/1060/002

47764

ORIFARM GENERICS A/S

SE

DK/H/1060/001

34484

ORIFARM GENERICS A/S

DK

DK/H/1060/002

34485

ORIFARM GENERICS A/S

DK

DK/H/1060/001

07-5310

ORIFARM GENERICS A/S

NO

DK/H/1060/002

07-5311

ORIFARM GENERICS A/S

NO

DK/H/1060/002

24197

ORIFARM GENERICS A/S

FI

DK/H/1060/001

71369.00.00

GALENPHARMA GMBH

DE

DK/H/1060/002

71368.00.00

GALENPHARMA GMBH

DE

mjúk ISOMACNE, BLØDE KAPSLER ISOMACNE, BLØDE KAPSLER Decutan 10mg Soft Capsules Decutan 20mg Soft Capsules Isotretinoin Orifarm 10 mg kapslar, mjuka Isotretinoin Orifarm 20 mg kapslar, mjuka Isotretinoin ”Orifarm”, bløde kapsler Isotretinoin ”Orifarm”, bløde kapsler Isotretinoin Orifarm 10 mg kapsler, myke Isotretinoin Orifarm 20 mg kapsler, myke Isotretinoin Orifarm 20 mg kapseli, pehmeä IsoGalen® 20 mg Weichkapseln IsoGalen® 10 mg Weichkapseln

List of nationally authorised medicinal products EMA/787886/2017

Page 23/30

Product Name (in authorisation country)

MRP/DCP Authorisation number

National Authorisation Number

MAH of product in the member state

Member State where product is authorised

Rizuderm 5mg Capsules

not available

PL 16853/0132

ALLIANCE

UK

PHARMACEUTICALS LTD Isotretinoin 20mg

not available

PL 16853/0133

Capsules Isotretinoin 5mg

UK

PHARMACEUTICALS LTD not available

PL 16853/0132

Capsules Rizuderm 20mg Capsules

ALLIANCE ALLIANCE

UK

PHARMACEUTICALS LTD not available

PL 16853/0133

ALLIANCE

UK

PHARMACEUTICALS LTD A-CNOTREN 10 mg

DK/H/0889/001

45/16-01-2012

PHARMATHEN HELLAS S.A.

GR

A-cnotren

not available

45047/10/18-04-2012

PHARMATHEN HELLAS S.A.

GR

FLEXRESAN 10 mg

not available

66.160

ESPECIALIDADES

ES

καψάκια

cápsulas blandas

FARMACEUTICAS CENTRUM, S.A

Axotret 10 mg, kapsułki,

not available

11318

AXXON SP. Z O.O.

PL

not available

11319

AXXON SP. Z O.O.

PL

UK/H/666/01

BE130611

N.V. ROCHE S.A.

BE

UK/H/666/01

BE130611

N.V. ROCHE S.A.

BE

UK/H/666/02

BE130627

N.V. ROCHE S.A.

BE

UK/H/666/02

BE130627

N.V. ROCHE S.A.

BE

UK/H/0666/001

9220

ROCHE OY

FI

miękkie Axotret 20 mg, kapsułki, miękkie Roaccutane 10 mg zachte capsules Roaccutane 10 mg Weichkapseln Roaccutane 20 mg zachte capsules Roaccutane 20 mg Weichkapseln Roaccutan 10 mg pehmeät kapselit List of nationally authorised medicinal products EMA/787886/2017

Page 24/30

Product Name (in authorisation country)

MRP/DCP Authorisation number

National Authorisation Number

MAH of product in the member state

Member State where product is authorised

Roaccutan 20 mg mjuka

UK/H/0666/002

9221

ROCHE OY

FI

UK/H/0666/001

PL 00031/0617

ROCHE PRODUCTS LTD

UK

UK/H/0666/002

PL 00031/0160

ROCHE PRODUCTS LTD

UK

UK/H/0666/001

PA50/53/5

ROCHE PRODUCTS LTD

IE

UK/H/0666/002

PA50/53/4

ROCHE PRODUCTS LTD

IE

UK-H-666

0178/10010651

N.V. ROCHE S.A.

LU

UK-H-666

0178/10040736

N.V. ROCHE S.A.

LU

UK/H/0666/001

H/96/01368/002

ROCHE FARMACEVTSKA

SI

kapslar Roaccutane 10 mg soft capsules Roaccutane 20 mg soft capsules Roaccutane 10 mg Soft Capsules Roaccutane 20 mg Soft Capsules Roaccutane 10 mg Weichkapseln Roaccutane 20 mg Weichkapseln Roaccutane 10 mg mehke kapsule Roaccutane 10 mg mehke

DRUŽBA D.O.O. UK/H/0666/001

H/96/01368/003

kapsule Roaccutane 20 mg mehke

UK/H/0666/002

H/96/01368/007

UK/H/0666/002

H/96/01368/008

UK/H/0666/001

H/96/01368/004

ROCHE FARMACEVTSKA

SI

ROCHE FARMACEVTSKA

SI

DRUŽBA D.O.O. UK/H/0666/002

H/96/01368/006

kapsule Roaccutane 20 mg,

SI

DRUŽBA D.O.O.

kapsule Roaccutane 20 mg mehke

ROCHE FARMACEVTSKA DRUŽBA D.O.O.

kapsule Roaccutane 10 mg mehke

SI

DRUŽBA D.O.O.

kapsule Roaccutane 20 mg mehke

ROCHE FARMACEVTSKA

ROCHE FARMACEVTSKA

SI

DRUŽBA D.O.O. NL/H/666/002

404002

ROCHE EESTI OÜ

EE

pehmekapslid

List of nationally authorised medicinal products EMA/787886/2017

Page 25/30

Product Name (in authorisation country)

MRP/DCP Authorisation number

National Authorisation Number

MAH of product in the member state

Member State where product is authorised

Roaccutane 10 mg,

UK/H/0666/001

052294

ROCHE EESTI OÜ

EE

UK/H/0666/001

0178/10010651

N.V. ROCHE S.A.

LU

UK/H/0666/002

0178/10040736

N.V. ROCHE S.A.

LU

UK/H/0666/001

9220

ROCHE OY

FI

UK/H/0666/002

9221

ROCHE OY

FI

UK/H/666/02

BE130627

N.V. ROCHE S.A.

BE

UK/H/666/01

BE130611

N.V. ROCHE S.A.

BE

UK/H/0666/001

OGYI-T-1278/01

ROCHE (MAGYARORSZÁG)

HU

pehmekapslid Roaccutane 10 mg capsules molles Roaccutane 20 mg capsules molles Roaccutan 10 mg pehmeät kapselit Roaccutan 20 mg pehmeät kapselit Roaccutane 20 mg capsules molles Roaccutane 10 mg capsules molles Roaccutan 10 mg lágy kapszula Roaccutan 20 mg lágy

KFT UK/H/0666/002

OGYI-T-1278/02

kapszula Roaccutane 20 mg mäkké

ROCHE (MAGYARORSZÁG)

HU

KFT UK/H/0666/002

46/0361/05-S

ROCHE SLOVENSKO S.R.O.

SK

UK/H/0666/001

46/0360/05-S

ROCHE SLOVENSKO S.R.O.

SK

UK/H/666/001

H/96/01368/001

ROCHE FARMACEVTSKA

SI

kapsuly Roaccutane 10 mg mäkké kapsuly Roaccutane 10 mg mehke kapsule Roaccutane 20 mg mehke

DRUŽBA D.O.O. UK/H/666/002

H/96/01368/005

kapsule Roaccutane 10 mg

ROCHE FARMACEVTSKA

SI

DRUŽBA D.O.O. UK/H/0666/001

LT/1/05/0406/003

UAB "ROCHE LIETUVA"

LT

minkštosios kapsulės

List of nationally authorised medicinal products EMA/787886/2017

Page 26/30

Product Name (in authorisation country)

MRP/DCP Authorisation number

National Authorisation Number

MAH of product in the member state

Member State where product is authorised

Roaccutane 10 mg

UK/H/0666/001

LT/1/05/0406/001

UAB "ROCHE LIETUVA"

LT

UK/H/0666/002

LT/1/05/0406/006

UAB "ROCHE LIETUVA"

LT

UK/H/0666/001

05-0517

ROCHE LATVIJA SIA

LV

UK/H/0666/001

LT/1/05/0406/004

UAB "ROCHE LIETUVA"

LT

UK/H/0666/002

LT/1/05/0406/008

UAB "ROCHE LIETUVA"

LT

UK/H/0666/002

LT/1/05/0406/007

UAB "ROCHE LIETUVA"

LT

UK/H/0666/002

05-0518

ROCHE LATVIJA SIA

LV

UK/H/0666/002

LT/1/05/0406/005

UAB "ROCHE LIETUVA"

LT

UK/H/0666/001

LT/1/05/0406/002

UAB "ROCHE LIETUVA"

LT

Sotret 10 mg capsule moi

not available

6765/2014/01

TERAPIA S.A.

RO

Sotret 20 mg capsule moi

not available

6766/2014/01

TERAPIA S.A.

RO

Sotret 20 mg lágy

not available

OGYI-T-8989/07

TERAPIA S.A.

HU

not available

OGYI-T-8989/06

TERAPIA S.A.

HU

not available

OGYI-T-8989/05

TERAPIA S.A.

HU

minkštosios kapsulės Roaccutane 20 mg minkštosios kapsulės Roaccutane 10 mg mīkstās kapsulas Roaccutane 10 mg minkštosios kapsulės Roaccutane 20 mg minkštosios kapsulės Roaccutane 20 mg minkštosios kapsulės Roaccutane 20 mg mīkstās kapsulas Roaccutane 20 mg minkštosios kapsulės Roaccutane 10 mg minkštosios kapsulės

kapszula Sotret 20 mg lágy kapszula Sotret 20 mg lágy kapszula

List of nationally authorised medicinal products EMA/787886/2017

Page 27/30

Product Name (in authorisation country)

MRP/DCP Authorisation number

National Authorisation Number

MAH of product in the member state

Member State where product is authorised

Sotret 10 mg lágy

not available

OGYI-T-8989/01

TERAPIA S.A.

HU

not available

OGYI-T-8989/08

TERAPIA S.A.

HU

not available

OGYI-T-8989/02

TERAPIA S.A.

HU

not available

OGYI-T-8989/04

TERAPIA S.A.

HU

not available

OGYI-T-8989/03

TERAPIA S.A.

HU

DK/H/1747/001

37461

ACTAVIS GROUP PTC EHF.

DK

DK/H/1747/001

27968

ACTAVIS GROUP PTC EHF.

FI

NL/H/902/001

RVG 27575

PHARMACHEMIE B.V

NL

not available

BE266533

LABORATOIRES SMB S.A.

BE

not available

BE266533

LABORATOIRES SMB S.A.

BE

not available

BE 266533

LABORATOIRES SMB S.A.

BE

not available

BE266542

LABORATOIRES SMB S.A.

BE

not available

BE266542

LABORATOIRES SMB S.A.

BE

not available

BE 266542

LABORATOIRES SMB S.A.

BE

kapszula Sotret 20 mg lágy kapszula Sotret 10 mg lágy kapszula Sotret 10 mg lágy kapszula Sotret 10 mg lágy kapszula ISOTRETINOIN ”ACTAVIS ”, BLØDE KAPSLER 40 MG ISOTRETINOIN ACTAVIS 40 MG, KAPSELI, PEHMEÄ Isotretinoïne 10 PCH, capsules 10 mg ISOSUPRA LIDOSE 8 mg, gélules ISOSUPRA LIDOSE 8 mg, capsules, hard Isosupra Lidose 8 mg Hartkapsel ISOSUPRA LIDOSE 16 mg, gélules Isosupra Lidose 16 mg, capsules, hard Isosupra Lidose 16 mg Hartkapsel

List of nationally authorised medicinal products EMA/787886/2017

Page 28/30

Product Name (in authorisation country)

MRP/DCP Authorisation number

National Authorisation Number

MAH of product in the member state

Member State where product is authorised

FLEXRESAN 20 mg

not available

66.159

ESPECIALIDADES

ES

cápsulas blandas

FARMACEUTICAS CENTRUM, S.A

PROCUTA 5 mg, capsule

not available

34009 358 110 9 7

not available

34009 357 840 3 2

not available

34009 358 111 5 8

molle PROCUTA 5 mg, capsule

not available

34009 358 112 1 9

not available

34009 357 842 6 1

not available

34009 357 838 9 9

LABORATOIRES

not available

34009 358 108 4 7

LABORATOIRES

LABORATOIRES

FR FR FR

EXPANSCIENCE not available

34009 358 109 0 8

LABORATOIRES

FR

EXPANSCIENCE not available

34009 357 839 5 0

LABORATOIRES

FR

EXPANSCIENCE not available

34009 358 104 9 6

molle PROCUTA 20 mg, capsule

FR

EXPANSCIENCE

molle PROCUTA 20 mg, capsule

FR

EXPANSCIENCE

molle PROCUTA 10 mg, capsule

LABORATOIRES

34009 358 107 8 6

molle PROCUTA 10 mg, capsule

LABORATOIRES

not available

molle PROCUTA 10 mg, capsule

FR

EXPANSCIENCE

molle PROCUTA 10 mg, capsule

LABORATOIRES

EXPANSCIENCE

molle PROCUTA 10 mg, capsule

FR

EXPANSCIENCE

molle PROCUTA 5 mg, capsule

LABORATOIRES EXPANSCIENCE

molle PROCUTA 5 mg, capsule

FR

EXPANSCIENCE

molle PROCUTA 5 mg, capsule

LABORATOIRES

LABORATOIRES

FR

EXPANSCIENCE not available

molle

List of nationally authorised medicinal products EMA/787886/2017

34009 357 836 6 0

LABORATOIRES

FR

EXPANSCIENCE

Page 29/30

Product Name (in authorisation country)

MRP/DCP Authorisation number

National Authorisation Number

MAH of product in the member state

Member State where product is authorised

PROCUTA 20 mg, capsule

not available

34009 358 105 5 7

LABORATOIRES

FR

molle PROCUTA 20 mg, capsule

EXPANSCIENCE not available

34009 358 106 1 8

molle PROCUTA 20 mg, capsule

FR

EXPANSCIENCE not available

34009 357 837 2 1

molle PROCUTA 40 mg, capsule

LABORATOIRES LABORATOIRES

FR

EXPANSCIENCE not available

molle

List of nationally authorised medicinal products EMA/787886/2017

34009 367 880 8 4

LABORATOIRES

FR

EXPANSCIENCE

Page 30/30

Isotretinoin - European Medicines Agency - Europa EU

Nov 30, 2017 - List of nationally authorised medicinal products. EMA/787886/2017. Page 5/30. Product Name (in authorisation country). MRP/DCP. Authorisation number. National Authorisation Number. MAH of product in the ..... 18066/21-03-2012. NEXUS MEDICALS S.A.. GR. Accuran, 20 mg/cap, καψάκιο, μαλακό.

283KB Sizes 54 Downloads 295 Views

Recommend Documents

Isotretinoin (oral formulations) - European Medicines Agency - Europa ...
Jul 19, 2017 - Telephone +44 (0)20 3660 6000 Facsimile +44 (0)20 3660 5525. Send a question via our ... List of nationally authorised medicinal products.

Agenda - European Medicines Agency - Europa EU
Jul 7, 2017 - COMMUNITY MARKETING AUTHORISATIONS AND EXTENSIONS. 2.1. Opinions ... Quality. Rapp: E. Werner .... solutions table with EMA and CVMP responses to the recommendations made by the FishMed Plus. Coalition ...

May 2016 - European Medicines Agency - Europa EU
Jun 22, 2016 - Information Management Division ... This document provides current information related to the volume and evaluation of .... Plasma master file.

Eleclazine - European Medicines Agency - Europa EU
Feb 9, 2017 - Notification of discontinuation of a paediatric development which is covered by an agreed ... for the following reason(s): (tick all that apply).

July 2017 - European Medicines Agency - Europa EU
Jul 5, 2017 - Send a question via our website www.ema.europa.eu/contact ... non-proprietary names (INN) and therapeutic areas for all new ... also available in the monthly reports of the Committee for Orphan Medicinal Products (COMP).

July 2016 - European Medicines Agency - Europa EU
Jul 4, 2016 - Send a question via our website www.ema.europa.eu/contact ... non-proprietary names (INN) and therapeutic areas for all new ... also available in the monthly reports of the Committee for Orphan Medicinal Products (COMP).

SME Office - European Medicines Agency - Europa EU
maximises the chances of a successful marketing authorisation. ... marketing authorisation. • inclusion in the public SME ... E-mail [email protected]. Website ...

Agenda - European Medicines Agency - Europa EU
Jun 19, 2017 - and may also vary during the course of the review. ...... ViiV Healthcare UK Limited; Treatment of Human Immunodeficiency Virus ..... adjunctive administration of brivaracetam, Treatment of paediatric patients with partial.

Action plan - European Medicines Agency - Europa EU
5 days ago - Guidelines should include more details on the principles of good information design in which content and layout are ... relevance and importance of the QRD template is also acknowledged in this respect as it is the main tool .... databas

Agenda - European Medicines Agency - Europa EU
Jun 15, 2016 - Agenda - EMA Human Scientific Committees' Working. Parties with Healthcare Professionals' Organisations. (HCPWP) meeting. 15 June 2016, 08:45hrs to 10:30hrs – meeting room: 3E. Chairs: I. Moulon (EMA) and Gonzalo Calvo (HCPWP). 15 Ju

Agenda - European Medicines Agency - Europa EU
Jun 26, 2018 - oxadiazole-3-carboximidamide - EMEA-002072-PIP01-16-M01 . ..... Human alpha-galactosidase A - Orphan - EMEA-001828-PIP01-15-M01 .

Agenda - European Medicines Agency - Europa EU
Jul 16, 2018 - Cladribine, EMA/OD/087/17 Recombinant monoclonal antibody to sialic acid-binding Ig-like lectin 8. 2.2.6. - EMA/OD/098/18. Treatment of ...

SPOR - European Medicines Agency - Europa EU
Feb 7, 2017 - Add an existing Tag to a specific Term . ...... This service creates an email body (text/html) of a user's notification data, a notification is based on.

ATMP - European Medicines Agency - Europa EU
Nov 24, 2017 - E8. 09/08/2017. 10/08/2017. 24/08/2017 17/08/2017 22/08/2017. 24/08/2017. 30/08/2017. 01/09/2017. 04/09/2017. 08/09/2017. 14/09/2017.

Agenda - European Medicines Agency - Europa EU
Feb 9, 2018 - 30 Churchill Place ○ Canary Wharf ○ London E14 5EU ○ United Kingdom. An agency of the European Union ... product information. For information: Summary of opinion. 2.2. Oral explanations and list of outstanding issues. •. Product

Agenda - European Medicines Agency - Europa EU
Oct 23, 2017 - Page 2/61. Table of contents. 1. Introduction. 11. 1.1. Welcome and declarations of interest of members, alternates and experts .......... 11. 1.2. Agenda of the meeting on 23-26 October 2017 . ...... different database to study the ri

Evofosfamide - European Medicines Agency - Europa EU
Notification of discontinuation of a paediatric development which is covered by an agreed ... for the following reason(s): (tick all that apply). (possible) lack of ...

Agenda - European Medicines Agency - Europa EU
17 Jan 2018 - Expert meeting on adeno-associated viral vectors, 06 September 2017, EMA, London. CAT: Martina Schüßler-Lenz. Scope: report of the meeting that took place on 6 September 2017. Action: for adoption. 7.6.3. Environmental assessment of g

minoxidil - European Medicines Agency - Europa EU
Jun 14, 2018 - Page 2/26. Product Name (in authorisation country). MRP/DCP Authorisation number. National Authorisation. Number. MAH of product in the.

Influenza vaccine - European Medicines Agency - Europa EU
Oct 26, 2017 - Injektionssuspension in einer Fertigspritze. Influenza-Impfstoff. (Spaltimpfstoff, inaktiviert, in Zellkulturen hergestellt) not available. BE393556. NANOTHERAPEUTICS. BOHUMIL, S.R.O.. BE. Preflucel injektionsvätska, suspension i för

latanoprost - European Medicines Agency - Europa EU
May 13, 2016 - Send a question via our website www.ema.europa.eu/contact. © European ... Product Name (in authorisation ..... Xaloptic Free. NL/H/3193/001.

Cyproterone/ethinylestradiol - European Medicines Agency - Europa EU
March 2016 a joint database drug utilisation final study report to the European .... With regards to prescription of CPA/EE for contraceptive management, ...

ganciclovir - European Medicines Agency - Europa EU
Feb 9, 2017 - Send a question via our website www.ema.europa.eu/contact. © European ... Product Name (in authorisation ... not available. 20010180.

July 2016 - European Medicines Agency - Europa EU
For a list of RSS readers please refer to our RSS guide and follow the instructions ..... PCWP and HCPWP joint meeting: Workshop on social media - Sep 2016.